J. Goldman & Co’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-377,972
Closed -$1.61M 485
2024
Q4
$1.61M Sell
377,972
-84,556
-18% -$322K 0.04% 292
2024
Q3
$1.36M Buy
462,528
+24,086
+5% +$76.7K 0.04% 261
2024
Q2
$1.53M Buy
+438,442
New +$1.46M 0.04% 269
2023
Q2
Sell
-255,563
Closed -$864K 387
2023
Q1
$864K Buy
+255,563
New +$1.04M 0.04% 239

Other funds holding SRTA

J. Goldman & Co's SRTA Position: Q1 2025 in Review

J. Goldman & Co sold out of Strata Critical Medical Inc (SRTA) in Q1 2025, closing a stake of 377,972 shares — an estimated $1.61M sold.

J. Goldman & Co first reported a position in SRTA in Q1 2023 and held it in 4 quarters. The position peaked at $1.61M in Q4 2024. 118 funds tracked by Wall St. Rank hold SRTA as of Q1 2025.

  • J. Goldman & Co reported no remaining Strata Critical Medical Inc position as of Q1 2025 after selling out during the quarter.
  • J. Goldman & Co sold 377,972 Strata Critical Medical Inc shares in Q1 2025, an estimated $1.61M.
  • J. Goldman & Co first reported a position in Strata Critical Medical Inc in Q1 2023 and held it in 4 quarters.
  • J. Goldman & Co's Strata Critical Medical Inc position peaked at $1.61M in Q4 2024.
  • 118 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2025.

Based on J. Goldman & Co's 13F filing for Q1 2025, filed 15 May 2025.